In healthy dogs, cerebrospinal fluid circulates freely around the brain and spinal cord, helping to protect and nourish the nervous system. In dogs predisposed to Syringomyelia, abnormalities in skull shape and brain positioning can obstruct this fluid flow. Over time, altered fluid dynamics may lead to the formation of syrinxes within the spinal cord. These fluid-filled cavities can place pressure on nerve tissue, resulting in chronic pain and neurological dysfunction.
Clinical signs of Syringomyelia can vary widely in severity and often develop gradually. One of the most characteristic symptoms is persistent scratching around the neck, shoulders, ears, or chest, often without making direct contact with the skin, a behavior sometimes referred to as "air scratching." Affected dogs may also display neck pain, sensitivity to touch, vocalization without an obvious cause, reluctance to exercise, weakness, balance problems, reduced coordination, or changes in posture. In more advanced cases, neurological deficits and mobility issues may become increasingly pronounced.
The SM Genetic Health Test is designed to identify genetic markers associated with an increased risk of developing Syringomyelia. It is important to note that Syringomyelia is considered a complex condition influenced by multiple genetic and environmental factors. Therefore, genetic testing is often used alongside clinical evaluations, pedigree analysis, and diagnostic imaging such as MRI scans to assess an individual dog's risk.
Testing is simple and non-invasive, typically requiring a cheek swab or blood sample. The collected sample is analyzed in a specialized laboratory to evaluate the dog's genetic status. Since DNA remains unchanged throughout life, testing can be performed at any age.
Results may be reported according to the laboratory's specific testing protocol and generally provide information regarding genetic risk, carrier status, or the presence of disease-associated variants.
Genetic testing for SM offers valuable information for breeders, veterinarians, and dog owners. Breeders can use test results in combination with clinical screening programs to make informed breeding decisions aimed at reducing the prevalence of Syringomyelia while maintaining healthy genetic diversity within the breed population. Responsible breeding practices are particularly important in breeds known to have a higher incidence of the condition.
For dog owners, understanding a dog's genetic risk can support proactive health monitoring and early veterinary evaluation if symptoms arise. Dogs at increased risk may benefit from regular neurological examinations and, when appropriate, advanced imaging studies. Early diagnosis can help guide treatment strategies that may include pain management, medical therapy, lifestyle modifications, or surgical intervention in selected cases.
The Syringomyelia (SM) Health Test is a valuable genetic screening tool that supports responsible breeding practices, promotes canine neurological health, and helps reduce the impact of this potentially debilitating condition. Through genetic awareness, clinical screening, and informed breeding decisions, breeders and owners can contribute to healthier dogs and improved long-term welfare.
